73 related articles for article (PubMed ID: 34288451)
1. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of somatic mutation in unexplained blood cytopenia.
Malcovati L; Gallì A; Travaglino E; Ambaglio I; Rizzo E; Molteni E; Elena C; Ferretti VV; Catricalà S; Bono E; Todisco G; Bianchessi A; Rumi E; Zibellini S; Pietra D; Boveri E; Camaschella C; Toniolo D; Papaemmanuil E; Ogawa S; Cazzola M
Blood; 2017 Jun; 129(25):3371-3378. PubMed ID: 28424163
[TBL] [Abstract][Full Text] [Related]
3. Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study.
Nann D; Rau A; Mahmutovic L; Steinhilber J; Meca V; Federmann B; Vogel W; Bonzheim I; Quintanilla-Martinez L; Fend F
Virchows Arch; 2023 Dec; 483(6):835-845. PubMed ID: 37610626
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS-IT).
O'Neill C; Nwachukwu N; Vergara-Lluri M; Hagiya A; O'Connell CL
Eur J Haematol; 2024 Apr; 112(4):594-600. PubMed ID: 38088145
[TBL] [Abstract][Full Text] [Related]
5. Clonal hematopoiesis in unexplained cytopenias.
Wu HY; Gu CY; Liu S; Dong QF; Dong L; Wang L; Wang XR; Cui SY; Li Z; Liu XG; Ma DX; Ji CY
Am J Hematol; 2023 Dec; 98(12):E407-E410. PubMed ID: 37782754
[No Abstract] [Full Text] [Related]
6. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
Craven KE; Ewalt MD
Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow histology of cytopenias : Contribution to hematological differential diagnosis].
Kreipe H
Pathologie (Heidelb); 2024 Mar; 45(2):148-158. PubMed ID: 38381371
[TBL] [Abstract][Full Text] [Related]
8. Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.
Pietka G; De Lord C; Matthias G; Cheung B; Atwal S; Furtado M; Cullis J; Grey-Davies L; Narayanan S; McGregor A; Kilner M; Bosworth J; McMullin MF; Coats T; Parcharidou A; Cavenagh J; Byrne J; Iyengar S; Mohammed K; Cross N; Hubank M; Ribeiro S; Khorashad J; Wren D; O'Connor S; Taussig D
Br J Haematol; 2024 Apr; 204(4):1325-1334. PubMed ID: 38462984
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
Molteni E; Bono E; Gallì A; Elena C; Ferrari J; Fiorelli N; Pozzi S; Ferretti VV; Sarchi M; Rizzo E; Camilotto V; Boveri E; Cazzola M; Malcovati L
Blood; 2023 Aug; 142(7):643-657. PubMed ID: 37216690
[TBL] [Abstract][Full Text] [Related]
10. Deciphering cytopenias in internal medicine: a single-center observational study.
Leoni S; Ferraresi M; Motta I; Hu C; Fracanzani AL; Barcellini W; Fattizzo B
Intern Emerg Med; 2024 Apr; 19(3):661-668. PubMed ID: 38270774
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Cytopenia in the General Population-A National Health and Nutrition Examination Survey Analysis.
Alpert N; Rapp JL; Mascarenhas J; Scigliano E; Tremblay D; Marcellino BK; Taioli E
Front Oncol; 2020; 10():579075. PubMed ID: 33330056
[TBL] [Abstract][Full Text] [Related]
12. The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance.
Li MM; Baranwal A; Gurney M; Shah SN; Al-Kali A; Alkhateeb HB; Foran JM; Arana-Yi C; Ongie L; Chen D; Mangaonkar AA; McCullough K; Tefferi A; Lasho TL; Finke CM; Patnaik MM; Shah MV
Blood Adv; 2024 Apr; ():. PubMed ID: 38564774
[TBL] [Abstract][Full Text] [Related]
13. Genetics of Myelodysplastic Syndromes.
Saygin C; Godley LA
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298596
[TBL] [Abstract][Full Text] [Related]
14. Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications.
Elena C; Gallì A; Bono E; Todisco G; Malcovati L
Curr Opin Hematol; 2021 Sep; 28(5):347-355. PubMed ID: 34342292
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?
Kasprzak A; Kaivers J; Nachtkamp K; Haas R; Kobbe G; Gattermann N; Germing U
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300079
[TBL] [Abstract][Full Text] [Related]
16. Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
Nazha A; Komrokji R; Meggendorfer M; Jia X; Radakovich N; Shreve J; Hilton CB; Nagata Y; Hamilton BK; Mukherjee S; Al Ali N; Walter W; Hutter S; Padron E; Sallman D; Kuzmanovic T; Kerr C; Adema V; Steensma DP; Dezern A; Roboz G; Garcia-Manero G; Erba H; Haferlach C; Maciejewski JP; Haferlach T; Sekeres MA
J Clin Oncol; 2021 Nov; 39(33):3737-3746. PubMed ID: 34406850
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathologic challenges of clonal cytopenia of undetermined significance.
Weinberg OK
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():82-85. PubMed ID: 34288451
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS).
Steensma DP
Curr Hematol Malig Rep; 2019 Dec; 14(6):536-542. PubMed ID: 31696381
[TBL] [Abstract][Full Text] [Related]
19. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
